Policy

• 

  Learning Medicare’s ABCDs

  Medicare was established to help provide affordable health care coverage for older Americans. But Medicare beneficiaries with cancer can still face financial burdens related to their care.

  by Kate Yandell

• 

  A Missed Conversation

  Despite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.

  by Marcus A. Banks

• 

  In It for the Long Haul

  Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.

  by Kate Yandell

• 

  The Return to Work

  What happens if your workplace reopens before you're ready to return or you're an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.

  by Jen Tota McGivney

• 

  From the Editor-in-Chief

  Measuring a Cancer Drug’s Effectiveness

  Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?

  by William G. Nelson, MD, PhD

• 

  Forward Look

  Here Come the Biosimilars

  As patents expire on biologic drugs, cancer patients get new options.

  by Stephen Ornes

• 

  Policy Matters

  Racial and Ethnic Disparities in Multiple Myeloma Clinical Trials

  The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

  by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

• 

  Robotic Surgery and Cancer

  Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

  by Sue Rochman

• 

  Survivor Profile

  Sharing Her Strength

  Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

  by Lindsey Konkel

• 

  Pushing Progress Forward

  NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”

  by Kevin McLaughlin